文献速递类风湿关节炎

PD-1信号抑制类风湿关节炎中致病性Tph与效应CD4⁺T细胞功能

PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2026-07-03

该研究探讨PD-1、BTLA和TIGIT在类风湿关节炎(RA)滑膜CD4⁺T细胞中的表达与功能,发现这些抑制性受体优先表达于Tph和Tfh细胞;PD-L2 engagement广泛抑制致病性细胞因子产生,且经CRISPR敲除PD-1后效应消失;三维类器官中PD-L2减少ABC诱导,支持PD-1激动在RA中的治疗潜力。

要点

  • PD-1、BTLA和TIGIT优先表达于RA滑膜Tph和Tfh细胞。
  • PD-L2 engagement抑制Tph细胞IL-21和CXCL13及非Tph细胞TNF、IFN-γ、IL-2产生。
  • PD-L2在三维类器官中显著减少CD11c⁺CD21⁻T-bet⁺ABC诱导。

核心结论

  • PD-1激活可抑制来自不同部位的多种T细胞群体,包括RA滑膜中的Tph细胞,支持PD-1激动广泛抑制RA病理性T细胞反应的潜力。

研究设计与样本

  • 从RA滑膜液或对照扁桃体和血液中分离CD4⁺T细胞,与表达PD-L2、HVEM或CD155的人工抗原呈递细胞共培养。
  • 采用ELISA检测细胞因子,三维类器官培养结合流式细胞术评估PD-L2对ABC诱导的调节,单细胞RNA测序分析抑制性受体与配体表达。

主要发现

  • PD-1、BTLA和TIGIT优先表达于RA滑膜Tph和Tfh细胞。
  • PD-L2 engagement广泛抑制多个CD4⁺T细胞亚群的致病性细胞因子产生,包括Tph细胞的IL-21和CXCL13,以及PD-1⁺CXCR5⁻非Tph细胞的TNF、IFN-γ和IL-2。
  • CRISPR介导的PD-1敲除可消除上述效应,PD-L2也抑制扁桃体Tfh和非Tfh细胞的细胞因子产生。
  • 三维类器官中PD-L2显著减少CD11c⁺CD21⁻T-bet⁺ABC的诱导。

临床怎么用

  • PD-1激动策略可能广泛抑制RA中致病性Tph与效应CD4⁺T细胞功能,并减少ABC诱导。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Inhibitory receptor signalling represents a potential therapeutic strategy in rheumatoid arthritis (RA), but its effects across pathogenic CD4⁺ T cell subsets and T-B cell interactions remain incompletely defined. We aimed to delineate the expression and function of major inhibitory receptors, including PD-1, BTLA, and TIGIT, in RA synovial CD4⁺ T cells and to determine how receptor agonism modulates T cell effector functions and T-B cell interactions. METHODS: CD4⁺ T cells were isolated from RA synovial fluid or from tonsils and blood of controls. Cells were cocultured with artificial antigen-presenting cells (murine fibroblast L cells) expressing PD-L2, HVEM, or CD155, and cytokine production was measured by ELISA (Enzyme-Linked Immunosorbent Assay). Three-dimensional organoid cultures were employed to assess PD-L2-mediated regulation of age-associated B cell (ABC) induction by flow cytometry. Single-cell RNA sequencing profiled inhibitory receptor and ligand expression across T cell subsets. RESULTS: PD-1, BTLA, and TIGIT were preferentially expressed on T peripheral helper (Tph) and T follicular helper (Tfh) cells in RA synovium. Engagement of PD-L2 broadly suppressed pathogenic cytokine production across multiple CD4⁺ T cell subsets, including IL(Interleukin)-21 and CXCL13 in Tph cells and TNF (Tumor Necrosis Factor), IFN-γ (Interferon-γ), and IL-2 in PD-1⁺CXCR5⁻ non-Tph cells, with effects abolished by CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-mediated PD-1 disruption. PD-L2 also inhibited cytokine production by tonsillar Tfh and non-Tfh cells. In 3-dimensional organoids, PD-L2 significantly reduced the induction of CD11c⁺CD21⁻T-bet⁺ ABCs. CONCLUSIONS: PD-1 activation suppresses multiple T cell populations from diverse sites, including Tph cells in RA synovium. These results support the broad potential of PD-1 agonism to suppress pathologic T cell responses in RA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Higashioka K, Sowerby JM, Marks KE, et al. PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis. Ann Rheum Dis. 2026. PMID: 42399123. doi:10.1016/j.ard.2026.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。